Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Inovio reports positive data from Phase II Covid-19 DNA vaccine trial

pharmaceutical-technologyMay 12, 2021

Tag: INOVIO , COVID-19 , CELLECTRA , INO-4800

PharmaSources Customer Service